1. Home
  2. OPEN vs ARQT Comparison

OPEN vs ARQT Comparison

Compare OPEN & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPEN
  • ARQT
  • Stock Information
  • Founded
  • OPEN 2014
  • ARQT 2016
  • Country
  • OPEN United States
  • ARQT United States
  • Employees
  • OPEN N/A
  • ARQT N/A
  • Industry
  • OPEN Real Estate
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPEN Finance
  • ARQT Health Care
  • Exchange
  • OPEN Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • OPEN 4.9B
  • ARQT 2.1B
  • IPO Year
  • OPEN N/A
  • ARQT 2020
  • Fundamental
  • Price
  • OPEN $9.50
  • ARQT $16.93
  • Analyst Decision
  • OPEN Sell
  • ARQT Strong Buy
  • Analyst Count
  • OPEN 4
  • ARQT 7
  • Target Price
  • OPEN $1.45
  • ARQT $19.00
  • AVG Volume (30 Days)
  • OPEN 430.7M
  • ARQT 1.5M
  • Earning Date
  • OPEN 11-06-2025
  • ARQT 11-05-2025
  • Dividend Yield
  • OPEN N/A
  • ARQT N/A
  • EPS Growth
  • OPEN N/A
  • ARQT N/A
  • EPS
  • OPEN N/A
  • ARQT N/A
  • Revenue
  • OPEN $5,181,000,000.00
  • ARQT $263,464,999.00
  • Revenue This Year
  • OPEN N/A
  • ARQT $72.46
  • Revenue Next Year
  • OPEN $1.19
  • ARQT $32.00
  • P/E Ratio
  • OPEN N/A
  • ARQT N/A
  • Revenue Growth
  • OPEN 14.07
  • ARQT 99.50
  • 52 Week Low
  • OPEN $0.51
  • ARQT $8.03
  • 52 Week High
  • OPEN $10.70
  • ARQT $18.15
  • Technical
  • Relative Strength Index (RSI)
  • OPEN 72.18
  • ARQT 57.20
  • Support Level
  • OPEN $5.57
  • ARQT $15.13
  • Resistance Level
  • OPEN $10.70
  • ARQT $18.15
  • Average True Range (ATR)
  • OPEN 1.10
  • ARQT 0.67
  • MACD
  • OPEN 0.42
  • ARQT 0.08
  • Stochastic Oscillator
  • OPEN 82.12
  • ARQT 60.00

About OPEN Opendoor Technologies Inc

Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: